SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000945621-16-000664
Filing Date
2016-07-13
Accepted
2016-07-13 17:06:31
Documents
3
Period of Report
2016-07-12
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K aviragen8k.htm 8-K 14264
2 PRESS RELEASE DATED JULY 12, 2016. exhibit991.htm EX-99 14712
3 image00001.jpg GRAPHIC 5436
  Complete submission text file 0000945621-16-000664.txt   37942
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Aviragen Therapeutics, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 161766091
SIC: 2836 Biological Products, (No Diagnostic Substances)